An “Fc-Silenced” IgG1 Format With Extended Half-Life Designed for Improved Stability
Multiple mutation combinations in the IgG Fc have been characterized to tailor immune effector function or IgG serum persistence to fit desired biological outcomes for monoclonal antibody therapeutics. An unintended consequence of introducing mutations in the Fc (particularly the CH2 domain) can be...
Gespeichert in:
Veröffentlicht in: | Journal of pharmaceutical sciences 2017-04, Vol.106 (4), p.1008-1017 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1017 |
---|---|
container_issue | 4 |
container_start_page | 1008 |
container_title | Journal of pharmaceutical sciences |
container_volume | 106 |
creator | Borrok, M. Jack Mody, Neil Lu, Xiaojun Kuhn, Megan L. Wu, Herren Dall'Acqua, William F. Tsui, Ping |
description | Multiple mutation combinations in the IgG Fc have been characterized to tailor immune effector function or IgG serum persistence to fit desired biological outcomes for monoclonal antibody therapeutics. An unintended consequence of introducing mutations in the Fc (particularly the CH2 domain) can be a reduction in biophysical stability which can correlate with increased aggregation propensity, poor manufacturability, and lower solubility. Herein, we characterize the changes in IgG conformational and colloidal stability when 2 sets of CH2 mutations “TM” (L234F/L235E/P331S) and “YTE” (M252Y/S254T/T256E) are combined to generate an antibody format lacking immune receptor binding and exhibiting extended half-life. In addition to significantly lowered thermostability, we observe greater conformational flexibility for TM-YTE in CH2, increased self-association, and poorer solubility and aggregation profiles. To improve these properties, we dissected the contributions of individual mutations within TM-YTE on thermostability and substituted destabilizing mutations with new mutations that raise thermostability. One novel combination, FQQ-YTE (L234F/L235Q/K322Q/M252Y/S254T/T256E), had significantly improved conformational and colloidal stability, and was found to retain the same biological activities as TM-YTE (extended half-life and lack of antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity activity). Our engineering approach offers a way to improve the developability of antibodies containing Fc mutations while retaining tailored biological activity. |
doi_str_mv | 10.1016/j.xphs.2016.12.023 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1856592798</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022354916419490</els_id><sourcerecordid>1856592798</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-d90aa6c99cb9eb2fa7f4458a43c699b50b123e6ac118ede7b82973adf45fff743</originalsourceid><addsrcrecordid>eNp9kLtOxDAQRS0EguXxAxQoJU3C2ImTWKJBwMJKK1EAgs5ynDF4lcdiZxF0fAj8HF-ClwVKqnno3quZQ8g-hYQCzY9mycv80Scs9AllCbB0jYwoZxDnQIt1MgJgLE55JrbItvczAMiB802yxUrgBc_YiNyfdNHn2_tYx9e2wU5j_fn2EU0eLmg07l2rhujODo_R-cuAXY11dKkaE0-twegMvX3owsr0Lpq0c9c_h-F6UJVt7PC6SzaMajzu_dQdcjs-vzm9jKdXF5PTk2msM4AhrgUolWshdCWwYkYVJst4qbJU50JUHCrKUsyVprTEGouqZKJIVW0ybowpsnSHHK5ywwFPC_SDbK3X2DSqw37hJS15zgUrRBmkbCXVrvfeoZFzZ1vlXiUFuSQqZ3JJVC6JSspkIBpMBz_5i6rF-s_yizAIjlcCDF8-W3TSa_tN0jrUg6x7-1_-FzANiJ0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1856592798</pqid></control><display><type>article</type><title>An “Fc-Silenced” IgG1 Format With Extended Half-Life Designed for Improved Stability</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Borrok, M. Jack ; Mody, Neil ; Lu, Xiaojun ; Kuhn, Megan L. ; Wu, Herren ; Dall'Acqua, William F. ; Tsui, Ping</creator><creatorcontrib>Borrok, M. Jack ; Mody, Neil ; Lu, Xiaojun ; Kuhn, Megan L. ; Wu, Herren ; Dall'Acqua, William F. ; Tsui, Ping</creatorcontrib><description>Multiple mutation combinations in the IgG Fc have been characterized to tailor immune effector function or IgG serum persistence to fit desired biological outcomes for monoclonal antibody therapeutics. An unintended consequence of introducing mutations in the Fc (particularly the CH2 domain) can be a reduction in biophysical stability which can correlate with increased aggregation propensity, poor manufacturability, and lower solubility. Herein, we characterize the changes in IgG conformational and colloidal stability when 2 sets of CH2 mutations “TM” (L234F/L235E/P331S) and “YTE” (M252Y/S254T/T256E) are combined to generate an antibody format lacking immune receptor binding and exhibiting extended half-life. In addition to significantly lowered thermostability, we observe greater conformational flexibility for TM-YTE in CH2, increased self-association, and poorer solubility and aggregation profiles. To improve these properties, we dissected the contributions of individual mutations within TM-YTE on thermostability and substituted destabilizing mutations with new mutations that raise thermostability. One novel combination, FQQ-YTE (L234F/L235Q/K322Q/M252Y/S254T/T256E), had significantly improved conformational and colloidal stability, and was found to retain the same biological activities as TM-YTE (extended half-life and lack of antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity activity). Our engineering approach offers a way to improve the developability of antibodies containing Fc mutations while retaining tailored biological activity.</description><identifier>ISSN: 0022-3549</identifier><identifier>EISSN: 1520-6017</identifier><identifier>DOI: 10.1016/j.xphs.2016.12.023</identifier><identifier>PMID: 28057542</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animals ; benign blocker ; biotechnology ; calorimetry (DSC) ; CH2 ; developability ; Fc-silenced ; Gene Silencing ; Half-Life ; HEK293 Cells ; Humans ; IgG antibody ; Immunoglobulin Fc Fragments - chemistry ; Immunoglobulin Fc Fragments - genetics ; Immunoglobulin G - chemistry ; Immunoglobulin G - genetics ; immunology ; light scattering (dynamic) ; Mice, 129 Strain ; Mice, Inbred C57BL ; Mice, Transgenic ; Mutation - genetics ; pharmacokinetics ; protein aggregation ; Protein Stability ; Protein Structure, Secondary ; Protein Structure, Tertiary ; Receptors, IgG - chemistry ; Receptors, IgG - genetics ; thermal analysis</subject><ispartof>Journal of pharmaceutical sciences, 2017-04, Vol.106 (4), p.1008-1017</ispartof><rights>2017 American Pharmacists Association</rights><rights>Copyright © 2017 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-d90aa6c99cb9eb2fa7f4458a43c699b50b123e6ac118ede7b82973adf45fff743</citedby><cites>FETCH-LOGICAL-c400t-d90aa6c99cb9eb2fa7f4458a43c699b50b123e6ac118ede7b82973adf45fff743</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28057542$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Borrok, M. Jack</creatorcontrib><creatorcontrib>Mody, Neil</creatorcontrib><creatorcontrib>Lu, Xiaojun</creatorcontrib><creatorcontrib>Kuhn, Megan L.</creatorcontrib><creatorcontrib>Wu, Herren</creatorcontrib><creatorcontrib>Dall'Acqua, William F.</creatorcontrib><creatorcontrib>Tsui, Ping</creatorcontrib><title>An “Fc-Silenced” IgG1 Format With Extended Half-Life Designed for Improved Stability</title><title>Journal of pharmaceutical sciences</title><addtitle>J Pharm Sci</addtitle><description>Multiple mutation combinations in the IgG Fc have been characterized to tailor immune effector function or IgG serum persistence to fit desired biological outcomes for monoclonal antibody therapeutics. An unintended consequence of introducing mutations in the Fc (particularly the CH2 domain) can be a reduction in biophysical stability which can correlate with increased aggregation propensity, poor manufacturability, and lower solubility. Herein, we characterize the changes in IgG conformational and colloidal stability when 2 sets of CH2 mutations “TM” (L234F/L235E/P331S) and “YTE” (M252Y/S254T/T256E) are combined to generate an antibody format lacking immune receptor binding and exhibiting extended half-life. In addition to significantly lowered thermostability, we observe greater conformational flexibility for TM-YTE in CH2, increased self-association, and poorer solubility and aggregation profiles. To improve these properties, we dissected the contributions of individual mutations within TM-YTE on thermostability and substituted destabilizing mutations with new mutations that raise thermostability. One novel combination, FQQ-YTE (L234F/L235Q/K322Q/M252Y/S254T/T256E), had significantly improved conformational and colloidal stability, and was found to retain the same biological activities as TM-YTE (extended half-life and lack of antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity activity). Our engineering approach offers a way to improve the developability of antibodies containing Fc mutations while retaining tailored biological activity.</description><subject>Animals</subject><subject>benign blocker</subject><subject>biotechnology</subject><subject>calorimetry (DSC)</subject><subject>CH2</subject><subject>developability</subject><subject>Fc-silenced</subject><subject>Gene Silencing</subject><subject>Half-Life</subject><subject>HEK293 Cells</subject><subject>Humans</subject><subject>IgG antibody</subject><subject>Immunoglobulin Fc Fragments - chemistry</subject><subject>Immunoglobulin Fc Fragments - genetics</subject><subject>Immunoglobulin G - chemistry</subject><subject>Immunoglobulin G - genetics</subject><subject>immunology</subject><subject>light scattering (dynamic)</subject><subject>Mice, 129 Strain</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Transgenic</subject><subject>Mutation - genetics</subject><subject>pharmacokinetics</subject><subject>protein aggregation</subject><subject>Protein Stability</subject><subject>Protein Structure, Secondary</subject><subject>Protein Structure, Tertiary</subject><subject>Receptors, IgG - chemistry</subject><subject>Receptors, IgG - genetics</subject><subject>thermal analysis</subject><issn>0022-3549</issn><issn>1520-6017</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kLtOxDAQRS0EguXxAxQoJU3C2ImTWKJBwMJKK1EAgs5ynDF4lcdiZxF0fAj8HF-ClwVKqnno3quZQ8g-hYQCzY9mycv80Scs9AllCbB0jYwoZxDnQIt1MgJgLE55JrbItvczAMiB802yxUrgBc_YiNyfdNHn2_tYx9e2wU5j_fn2EU0eLmg07l2rhujODo_R-cuAXY11dKkaE0-twegMvX3owsr0Lpq0c9c_h-F6UJVt7PC6SzaMajzu_dQdcjs-vzm9jKdXF5PTk2msM4AhrgUolWshdCWwYkYVJst4qbJU50JUHCrKUsyVprTEGouqZKJIVW0ybowpsnSHHK5ywwFPC_SDbK3X2DSqw37hJS15zgUrRBmkbCXVrvfeoZFzZ1vlXiUFuSQqZ3JJVC6JSspkIBpMBz_5i6rF-s_yizAIjlcCDF8-W3TSa_tN0jrUg6x7-1_-FzANiJ0</recordid><startdate>201704</startdate><enddate>201704</enddate><creator>Borrok, M. Jack</creator><creator>Mody, Neil</creator><creator>Lu, Xiaojun</creator><creator>Kuhn, Megan L.</creator><creator>Wu, Herren</creator><creator>Dall'Acqua, William F.</creator><creator>Tsui, Ping</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201704</creationdate><title>An “Fc-Silenced” IgG1 Format With Extended Half-Life Designed for Improved Stability</title><author>Borrok, M. Jack ; Mody, Neil ; Lu, Xiaojun ; Kuhn, Megan L. ; Wu, Herren ; Dall'Acqua, William F. ; Tsui, Ping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-d90aa6c99cb9eb2fa7f4458a43c699b50b123e6ac118ede7b82973adf45fff743</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Animals</topic><topic>benign blocker</topic><topic>biotechnology</topic><topic>calorimetry (DSC)</topic><topic>CH2</topic><topic>developability</topic><topic>Fc-silenced</topic><topic>Gene Silencing</topic><topic>Half-Life</topic><topic>HEK293 Cells</topic><topic>Humans</topic><topic>IgG antibody</topic><topic>Immunoglobulin Fc Fragments - chemistry</topic><topic>Immunoglobulin Fc Fragments - genetics</topic><topic>Immunoglobulin G - chemistry</topic><topic>Immunoglobulin G - genetics</topic><topic>immunology</topic><topic>light scattering (dynamic)</topic><topic>Mice, 129 Strain</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Transgenic</topic><topic>Mutation - genetics</topic><topic>pharmacokinetics</topic><topic>protein aggregation</topic><topic>Protein Stability</topic><topic>Protein Structure, Secondary</topic><topic>Protein Structure, Tertiary</topic><topic>Receptors, IgG - chemistry</topic><topic>Receptors, IgG - genetics</topic><topic>thermal analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Borrok, M. Jack</creatorcontrib><creatorcontrib>Mody, Neil</creatorcontrib><creatorcontrib>Lu, Xiaojun</creatorcontrib><creatorcontrib>Kuhn, Megan L.</creatorcontrib><creatorcontrib>Wu, Herren</creatorcontrib><creatorcontrib>Dall'Acqua, William F.</creatorcontrib><creatorcontrib>Tsui, Ping</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Borrok, M. Jack</au><au>Mody, Neil</au><au>Lu, Xiaojun</au><au>Kuhn, Megan L.</au><au>Wu, Herren</au><au>Dall'Acqua, William F.</au><au>Tsui, Ping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>An “Fc-Silenced” IgG1 Format With Extended Half-Life Designed for Improved Stability</atitle><jtitle>Journal of pharmaceutical sciences</jtitle><addtitle>J Pharm Sci</addtitle><date>2017-04</date><risdate>2017</risdate><volume>106</volume><issue>4</issue><spage>1008</spage><epage>1017</epage><pages>1008-1017</pages><issn>0022-3549</issn><eissn>1520-6017</eissn><abstract>Multiple mutation combinations in the IgG Fc have been characterized to tailor immune effector function or IgG serum persistence to fit desired biological outcomes for monoclonal antibody therapeutics. An unintended consequence of introducing mutations in the Fc (particularly the CH2 domain) can be a reduction in biophysical stability which can correlate with increased aggregation propensity, poor manufacturability, and lower solubility. Herein, we characterize the changes in IgG conformational and colloidal stability when 2 sets of CH2 mutations “TM” (L234F/L235E/P331S) and “YTE” (M252Y/S254T/T256E) are combined to generate an antibody format lacking immune receptor binding and exhibiting extended half-life. In addition to significantly lowered thermostability, we observe greater conformational flexibility for TM-YTE in CH2, increased self-association, and poorer solubility and aggregation profiles. To improve these properties, we dissected the contributions of individual mutations within TM-YTE on thermostability and substituted destabilizing mutations with new mutations that raise thermostability. One novel combination, FQQ-YTE (L234F/L235Q/K322Q/M252Y/S254T/T256E), had significantly improved conformational and colloidal stability, and was found to retain the same biological activities as TM-YTE (extended half-life and lack of antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity activity). Our engineering approach offers a way to improve the developability of antibodies containing Fc mutations while retaining tailored biological activity.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>28057542</pmid><doi>10.1016/j.xphs.2016.12.023</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-3549 |
ispartof | Journal of pharmaceutical sciences, 2017-04, Vol.106 (4), p.1008-1017 |
issn | 0022-3549 1520-6017 |
language | eng |
recordid | cdi_proquest_miscellaneous_1856592798 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Animals benign blocker biotechnology calorimetry (DSC) CH2 developability Fc-silenced Gene Silencing Half-Life HEK293 Cells Humans IgG antibody Immunoglobulin Fc Fragments - chemistry Immunoglobulin Fc Fragments - genetics Immunoglobulin G - chemistry Immunoglobulin G - genetics immunology light scattering (dynamic) Mice, 129 Strain Mice, Inbred C57BL Mice, Transgenic Mutation - genetics pharmacokinetics protein aggregation Protein Stability Protein Structure, Secondary Protein Structure, Tertiary Receptors, IgG - chemistry Receptors, IgG - genetics thermal analysis |
title | An “Fc-Silenced” IgG1 Format With Extended Half-Life Designed for Improved Stability |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T00%3A25%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=An%20%E2%80%9CFc-Silenced%E2%80%9D%20IgG1%20Format%20With%20Extended%20Half-Life%20Designed%20for%20Improved%20Stability&rft.jtitle=Journal%20of%20pharmaceutical%20sciences&rft.au=Borrok,%20M.%20Jack&rft.date=2017-04&rft.volume=106&rft.issue=4&rft.spage=1008&rft.epage=1017&rft.pages=1008-1017&rft.issn=0022-3549&rft.eissn=1520-6017&rft_id=info:doi/10.1016/j.xphs.2016.12.023&rft_dat=%3Cproquest_cross%3E1856592798%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1856592798&rft_id=info:pmid/28057542&rft_els_id=S0022354916419490&rfr_iscdi=true |